|
| Exchange Disseminated Time 15/09/2015 17:22:04 | Natco Pharma Ltd has informed BSE that in respect of the QIP, the Committee of Directors (the "Committee") of the Company has at its meeting held on September 15, 2015, inter alia, approved the following:
1. Issue Price of Rs. 2,130.55, after giving discount of upto 5% i.e Rs. 112.13 per Equity Share, to the Floor Price of Rs. 2,242.68 per Equity Share as per the SEBI ICDR Regulations and shareholders' approval, for the Equity Shares to be issued and allotted to eligible Qualified Institutional Buyers in the QIP; and
2. Approval of issue of Confirmation Allocation Note for the allocation of 1,600,000 Equity Shares to the Qualified Institutional Buyers amounting to approximately Rs. 3,408.88 million.
3. Approved the Placement Document dated September 15, 2015. |
|
|